| This week's sponsor is Premier Research. | | | Atopic Dermatitis: Where Do We Go From Here?
Improved understanding of atopic dermatitis is revealing new insights and treatment options. Get current by downloading our white paper examining these exciting and emerging therapies. Premier Research. It's what we do. Best. |
Today's Rundown Moderna raises $500M to move mRNA drugs deeper into human tests AstraZeneca stops monotherapy study at centerpiece of $500M buyout Arcturus Therapeutics ousts CEO Joseph Payne New insights into dopamine release could mean better weapons against addiction Apple eyes FDA approval filing for investigational heart device EuroBiotech Report—Sanofi-Ablynx, COPD data, EMA move, AstraZeneca and Roche FiercePharmaAsia—Lantus biosimilar, Takeda’s Zika vaccine, Celltrion warning letter Chutes & Ladders—Hugin to retire from Celgene. Could Senate be next? Featured Story | | | Friday, February 2, 2018 Moderna has raised $500 million from private investors. The huge series G round equips Moderna to gather more data on its pipeline of mRNA candidates and build out its manufacturing capabilities ahead of its long-anticipated IPO. |
|
|
| This week's sponsor is Dell EMC. | | | [Webinar] Is Your Life Science Data "F-A-I-R"?
Tuesday, February 13 | 2pm ET / 11am PT
Is Your Life Science Data "F-A-I-R"? Join DataFrameworks & Dell EMC in this webinar to discover a new approach to create scientific data that is findable, accessible, interoperable, and reusable. Register now! |
Top Stories Friday, February 2, 2018 AstraZeneca has stopped monotherapy development of a PD-1 drug it acquired in a $500 million (€400 million) biotech buyout. The candidate, MEDI0680, was the centerpiece of AstraZeneca’s takeover of Amplimmune. Friday, February 2, 2018 Arcturus Therapeutics VP Mark Herbert will take over as interim president after the company’s board opted to terminate President and CEO Joseph Payne. Thursday, February 1, 2018 Harvard scientists discovered that neurons transfer dopamine to each other more quickly and specifically than previously thought. This new understanding could shed light on how dopamine signaling goes wrong in brain disorders, and it could lead to improved treatments for addiction, Parkinson's disease and more. Friday, February 2, 2018 Apple has told participants in its heart study that their data will be used to seek FDA approval for an investigational device, MobiHealthNews reports. The study is using Apple Watch sensors and related algorithms to identify irregular heart rhythms. Thursday, February 1, 2018 In this week's EuroBiotech Report, Sanofi is set to buy Ablynx, AstraZeneca posts COPD data, the EMA move gets complicated, plus more need-to-know news from Europe's biotech industry. Friday, February 2, 2018 Mylan and Biocon won an EU recommendation for approval of a Lantus biosimilar, Takeda’s Zika vaccine candidate won FDA fast-track status, Celltrion's South Korean plant was slapped with a warning letter, and more. Friday, February 2, 2018 Legendary Bob Hugin might run for the Senate after retiring from Celgene as executive chairman, Voyager founder and CEO will step aside to executive science adviser, Boehringer Ingelheim U.S. chief Fonteyne will retire, plus more hirings, firings and retirings throughout the industry. Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: Agilent This Agilent intact protein analysis includes: Sponsored by: Seton Hall Don’t miss this educational program trusted by multi-national companies as part of their employee’s compliance training. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating in the Asia-Pacific region. Visit event page for session topics. Presented by: Patheon Download Patheon’s whitepaper to discover two main areas where a drug developer can face significant obstacles during biologics development and how by evaluating these capabilities, it can answer the critical question of whether its in-house strategy is ready for these uncertainties. Presented by: SDC and Stiris Research What do you do when timelines are missed, data is dirty, and everyone is pointing fingers? Join this webinar to learn how to prevent, identify, and implement a successful clinical trial rescue. Sponsored by: Veeva Systems Expanding into new markets places a spotlight on inefficient processes. Sponsored by: Veeva Systems Regulatory leaders share challenges and best practices from a lack of standardization, manual processes, and fragmented systems. Sponsored by: WCG Selecting the right sites to conduct your clinical trials will determine the success or failure of meeting your enrollment goals. Sponsored by: Veeva Systems Read this guide if you’re a global life sciences company - conducting clinical trials across several countries, or manufacturing and distributing products in multiple regions - to learn five steps to align and improve quality oversight, as well as avoid common mistakes in harmonization initiatives. Presented By: Covance Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives. Presented By: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented By: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented By: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented By: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Drug Approval, Manufacturing Quality & Regulation 2018 | Online TMF Operations: a Quality and Regulatory Approach March 19 - 21, 2018 | Berlin, Germany
Drug Development Boot Camp® 2018 November 14-15, 2018 | Boston, MA MIXiii-Biomed 2018 May 15-17, 2018 | Tel-Aviv, Israel BioBasics: Biotech for the Non-Scientist March 29-30, 2018 | Boston, MA | 